The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA Action Update, January 2026: Approvals, Acceptance, and Clearance NeurologyLive Clinical Neurology News and Neurology Expert Insights Are Peptides FDA Approved? 2026 Legal List & Classification of 14 Peptides GHK Cu Copper Tripeptide 1 Research Reagent GHK CU Program Calibrate Hydration 2026 FDA Peptide Reclassification Purefico Medspa and Therapy